Neurology

Multiple Sclerosis Therapeutics

Name: Multiple Sclerosis Therapeutics
Author: Jeffrey A. Cohen
ISBN: 9780521766272

by Jeffrey A. Cohen (Editor), Richard A. Rudick (Editor)

Available on Bookshop Write a review

Books.org participates in affiliate programs including Bookshop.org and the Amazon Services LLC Associates Program. We may earn a commission from qualifying purchases made through links on this page, at no additional cost to you.

Overview

This revised textbook examines the most important aspects of multiple sclerosis that impact on clinical trial design, on the development of new disease therapies, and, very importantly, on patient care. The international team of contrib4tors discusses the clinical course of multiple sclerosis, its clinical heterogeneity, and the presence of subclinical disease activity that occurs during the early stages of the disease. There have been substantial advances in the field since the first edition was published in 1999. The previous chapters have been updated to reflect these new findings, and several new chapters have been added. Multiple sclerosis presents substantial clinical challenges, from unexpected and irregular relapses to progressive deterioration. The reader will find help with these challenges in Multiple Sclerosis Therapeutics (Second edition).

About the Author, Jeffrey A. Cohen

Jeffrey A. Cohen MD is Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

Richard A. Rudick MD is Director of the Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.